Yi Li1, Ran Yang1, Bo Hong1, ShuYang Dai1, Yong Zhan1, Wen-Bo Zhang2, Rui Dong3. 1. Department of Pediatric Surgery, Shanghai Key Laboratory of Birth Defect, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China. 2. Department of Pediatric Thoracic Surgery, Shanghai Key Laboratory of Birth Defect, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China. zwb-0303@163.com. 3. Department of Pediatric Surgery, Shanghai Key Laboratory of Birth Defect, Children's Hospital of Fudan University, 399 Wan Yuan Road, Shanghai, 201102, China. rdong@fudan.edu.cn.
Abstract
PURPOSE: Ewing sarcoma (EwS) is an aggressive malignant neoplasm composed of small round cells. The heterogeneity and developmental trajectories of EwS are uncertain. METHODS: Single-cell RNA sequencing was performed on 4 EwS tumor tissue samples, and 3 transcriptional atlases were generated. K-nearest neighbor algorithm was used to predict the origin of tumor cells at single-cell resolution. Monocle2 package was used to perform pseudotime trajectory analysis in tumor cells. Differentially expressed genes were compared against those in all other clusters via the FindMarkers function, and then they were subjected to GO analysis using clusterProfiler package. RESULTS: Combined with the results of k-nearest neighbor algorithm and pseudotime trajectory analysis in tumor cells, we thought meningeal EwS originated from neural crest cells during epithelial to mesenchymal transition and simulated the process of neural crest cell lineage differentiation. But for perirenal EwS and spinal EwS, we hypothesized that after the neural crest cell lineage mutated into them, the tumor cells did not maintain the differentiation trajectory of neural crest cell lineage, and the development trajectory of tumor cells became chaotic. GO analysis results showed that interferon signaling pathway-related biological processes play an essential role in the tumorigenesis and tumor progression process of EwS, and among these biological processes genes, JAK1 gene up-regulated most significantly and highly expressed in all tumor cells. Ruxolitinib was used to explore the function of JAK1. Targeting JAK1 can promote apoptosis of EwS tumor cells, inhibit the migration and invasion of EwS tumor cells, and inhibit cell proliferation by inducing cell cycle S phase arrest. CONCLUSION: EwS was derived from neural crest cell lineage with variable developmental timing of oncogenic conversion, and the JAK1 might be a candidate for therapeutic targets of EwS.
PURPOSE: Ewing sarcoma (EwS) is an aggressive malignant neoplasm composed of small round cells. The heterogeneity and developmental trajectories of EwS are uncertain. METHODS: Single-cell RNA sequencing was performed on 4 EwS tumor tissue samples, and 3 transcriptional atlases were generated. K-nearest neighbor algorithm was used to predict the origin of tumor cells at single-cell resolution. Monocle2 package was used to perform pseudotime trajectory analysis in tumor cells. Differentially expressed genes were compared against those in all other clusters via the FindMarkers function, and then they were subjected to GO analysis using clusterProfiler package. RESULTS: Combined with the results of k-nearest neighbor algorithm and pseudotime trajectory analysis in tumor cells, we thought meningeal EwS originated from neural crest cells during epithelial to mesenchymal transition and simulated the process of neural crest cell lineage differentiation. But for perirenal EwS and spinal EwS, we hypothesized that after the neural crest cell lineage mutated into them, the tumor cells did not maintain the differentiation trajectory of neural crest cell lineage, and the development trajectory of tumor cells became chaotic. GO analysis results showed that interferon signaling pathway-related biological processes play an essential role in the tumorigenesis and tumor progression process of EwS, and among these biological processes genes, JAK1 gene up-regulated most significantly and highly expressed in all tumor cells. Ruxolitinib was used to explore the function of JAK1. Targeting JAK1 can promote apoptosis of EwS tumor cells, inhibit the migration and invasion of EwS tumor cells, and inhibit cell proliferation by inducing cell cycle S phase arrest. CONCLUSION: EwS was derived from neural crest cell lineage with variable developmental timing of oncogenic conversion, and the JAK1 might be a candidate for therapeutic targets of EwS.
Authors: Matthew Brentnall; Luis Rodriguez-Menocal; Rebeka Ladron De Guevara; Enrique Cepero; Lawrence H Boise Journal: BMC Cell Biol Date: 2013-07-09 Impact factor: 4.241
Authors: Sander Lambo; Susanne N Gröbner; Tobias Rausch; Sebastian M Waszak; Christin Schmidt; Aparna Gorthi; July Carolina Romero; Monika Mauermann; Sebastian Brabetz; Sonja Krausert; Ivo Buchhalter; Jan Koster; Danny A Zwijnenburg; Martin Sill; Jens-Martin Hübner; Norman Mack; Benjamin Schwalm; Marina Ryzhova; Volker Hovestadt; Simon Papillon-Cavanagh; Jennifer A Chan; Pablo Landgraf; Ben Ho; Till Milde; Olaf Witt; Jonas Ecker; Felix Sahm; David Sumerauer; David W Ellison; Brent A Orr; Anna Darabi; Christine Haberler; Dominique Figarella-Branger; Pieter Wesseling; Jens Schittenhelm; Marc Remke; Michael D Taylor; Maria J Gil-da-Costa; Maria Łastowska; Wiesława Grajkowska; Martin Hasselblatt; Peter Hauser; Torsten Pietsch; Emmanuelle Uro-Coste; Franck Bourdeaut; Julien Masliah-Planchon; Valérie Rigau; Sanda Alexandrescu; Stephan Wolf; Xiao-Nan Li; Ulrich Schüller; Matija Snuderl; Matthias A Karajannis; Felice Giangaspero; Nada Jabado; Andreas von Deimling; David T W Jones; Jan O Korbel; Katja von Hoff; Peter Lichter; Annie Huang; Alexander J R Bishop; Stefan M Pfister; Andrey Korshunov; Marcel Kool Journal: Nature Date: 2019-12-04 Impact factor: 49.962
Authors: Andrew V Anzalone; Xin D Gao; Christopher J Podracky; Andrew T Nelson; Luke W Koblan; Aditya Raguram; Jonathan M Levy; Jaron A M Mercer; David R Liu Journal: Nat Biotechnol Date: 2021-12-09 Impact factor: 68.164
Authors: Emilie Barruet; Steven M Garcia; Katharine Striedinger; Jake Wu; Solomon Lee; Lauren Byrnes; Alvin Wong; Sun Xuefeng; Stanley Tamaki; Andrew S Brack; Jason H Pomerantz Journal: Elife Date: 2020-04-01 Impact factor: 8.140
Authors: Ugomma C Eze; Aparna Bhaduri; Maximilian Haeussler; Tomasz J Nowakowski; Arnold R Kriegstein Journal: Nat Neurosci Date: 2021-03-15 Impact factor: 24.884